Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?
| Image |  |
|---|---|
| Description | scientific article published on 2 June 2007 |
| Author/s |
author: Richard O. Day |
| Publication date | June 2, 2007 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |